With a rich background in finance and experience in the pharmaceutical sector, including roles at bluebird bio and Jubilant Pharma, Krawtschuk is expected to bring valuable insight to Eagle’s ...

Eagle Pharmaceuticals (EGRX) announced the appointment of Christopher ... Most recently, Mr. Krawtschuk served as CFO and Treasurer of bluebird bio. Published first on TheFly – the ultimate source for ...

Atrial arrhythmias were found in 26% of patients with sickle cell disease (SCD), with a significant association with stroke history. Early detection and treatment of atrial arrhythmias may help ...

Nobias Therapeutics, a clinical-stage company developing novel small-molecule therapeutics for rare diseases, has announced its intent to focus its resources on its development programs following ...

Visionaire Research & Education, an innovator in recruiting patients for veterinary clinical studies, is proud to announce the launch of its new website, vrande.com. This unique website explains how ...

bluebird had set an initial price of $1.8 million ... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.

Shares in bluebird ticked up following the announcement. Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.

Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, today announced the launch of its new Global Therapy Innovations business unit, designed to integrate disease expertise ...

AST SpaceMobile (NASDAQ:ASTS) shares fell 13% premarket on Friday after the communication services firm missed Wall Street ...

Representatives from the Cumberland County Prosecutor's Office and the Millville Police Department met with staff from Lowe's ...

OTTAWA, Nov 9 (Reuters) - Canada has detected its first presumptive case of H5 bird flu in a person, a teenager in the western province of British Columbia, health officials said on Saturday. The ...

Two comparable companies are possible futures, namely: Crisper Therapeutics (CRSP) and Bluebird Bio (BLUE). Crisper has a ...